Endoscope-assisted visualization of 5-aminolevulinic acid fluorescence in surgery for brain metastases
- PMID: 35535845
- DOI: 10.3171/2022.3.JNS212301
Endoscope-assisted visualization of 5-aminolevulinic acid fluorescence in surgery for brain metastases
Abstract
Objective: Fluorescence-guided resection of cerebral metastases has been proposed as an approach to visualize residual tumor tissue and maximize the extent of resection. Critics have argued that tumor cells at the resection margins might be overlooked under microscopic visualization because of technical limitations. Therefore, an endoscope, which is capable of inducing fluorescence, has been applied with the aim of improving exposure of fluorescent tumor tissue. In this retrospective analysis, authors assessed the utility of endoscope assistance in 5-aminolevulinic acid (5-ALA) fluorescence-guided resection of brain metastases.
Methods: Between June 2013 and December 2016, a standard 20-mg/kg dose of 5-ALA was administered 4 hours prior to surgery in 26 patients with suspected single brain metastases. After standard neuronavigated microsurgical tumor resection, a microscope capable of inducing fluorescence was used to examine tumor margins. The authors classified the remaining fluorescence into 3 grades (0 = none, 1 = weak, and 2 = strong). Endoscopic assistance was employed if no or only weak fluorescence was visualized at the resection margins under the microscope. Endoscopically identified fluorescent tissue at the margins was resected and evaluated separately via histological examination to prove or disprove tumor infiltration.
Results: Under the microscope, weakly fluorescent tissue was seen at the margins of the resection cavity in 15/26 (57.7%) patients. In contrast, endoscopic inspection revealed strongly fluorescent tissue in 22/26 (84.6%) metastases. In 11/26 (42.3%) metastases no fluorescence at the tumor margins was detected by the microscope; however, strong fluorescence was visualized under the endoscope in 7 (63.6%) of these 11 metastases. In the 15 metastases with microscopically weak fluorescence, strong fluorescence was seen when using the endoscope. Neither microscopic nor endoscopic fluorescence was found in 4/26 (15.4%) cases. In the 26 patients, 96 histological specimens were obtained from the margins of the resection cavity. Findings from these specimens were in conjunction with the histopathological findings, allowing identification of metastatic infiltration with a sensitivity of 95.5% and a specificity of 75% using endoscope assistance.
Conclusions: Fluorescence-guided endoscope assistance may overcome the technical limitations of the conventional microscopic exposure of 5-ALA-fluorescent metastases and thereby increase visualization of fluorescent tumor tissue at the margins of the resection cavity with high sensitivity and acceptable specificity.
Keywords: 5-ALA; brain metastases; endoscope; extent of resection; oncology.
Similar articles
-
Endoscope-assisted fluorescence-guided resection allowing supratotal removal in glioblastoma surgery.Neurosurg Focus. 2021 Jan;50(1):E3. doi: 10.3171/2020.10.FOCUS20560. Neurosurg Focus. 2021. PMID: 33386004
-
Endoscopic-assisted visualization of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery: a technical note.World Neurosurg. 2014 Jul-Aug;82(1-2):e277-9. doi: 10.1016/j.wneu.2013.07.002. Epub 2013 Jul 16. World Neurosurg. 2014. PMID: 23871813
-
From white to blue light: evolution of endoscope-assisted intracranial tumor neurosurgery and expansion to intraaxial tumors.J Neurosurg. 2022 Nov 11;139(1):59-64. doi: 10.3171/2022.10.JNS22489. Print 2023 Jul 1. J Neurosurg. 2022. PMID: 36681992
-
The impact of 5-aminolevulinic acid on extent of resection in newly diagnosed high grade gliomas: a systematic review and single institutional experience.J Neurooncol. 2019 Feb;141(3):507-515. doi: 10.1007/s11060-018-03061-3. Epub 2018 Dec 1. J Neurooncol. 2019. PMID: 30506501
-
Turning on the light for brain tumor surgery: A 5-aminolevulinic acid story.Neuro Oncol. 2022 Nov 2;24(Suppl 6):S52-S61. doi: 10.1093/neuonc/noac191. Neuro Oncol. 2022. PMID: 36322101 Free PMC article. Review.
Cited by
-
Second-Generation Wide-Field Visualization Devices for 5-ALA-Induced Fluorescence and Concepts for Validation in Neurosurgery-A Systematic Review.Neurosurg Pract. 2023 Oct 6;4(4):e00059. doi: 10.1227/neuprac.0000000000000059. eCollection 2023 Dec. Neurosurg Pract. 2023. PMID: 39959385 Free PMC article. Review.
-
Comparative efficacy and safety of sodium fluorescein-guided surgery versus standard white light for resection of brain metastases: a systematic review and meta-analysis.J Neurooncol. 2024 Sep;169(3):497-506. doi: 10.1007/s11060-024-04768-2. Epub 2024 Jul 30. J Neurooncol. 2024. PMID: 39078542
-
Intraoperative Imaging and Optical Visualization Techniques for Brain Tumor Resection: A Narrative Review.Cancers (Basel). 2023 Oct 9;15(19):4890. doi: 10.3390/cancers15194890. Cancers (Basel). 2023. PMID: 37835584 Free PMC article. Review.
-
Clinical Application of the Association between Genetic Alteration and Intraoperative Fluorescence Activity of 5-Aminolevulinic Acid during the Resection of Brain Metastasis of Lung Adenocarcinoma.Cancers (Basel). 2023 Dec 23;16(1):88. doi: 10.3390/cancers16010088. Cancers (Basel). 2023. PMID: 38201516 Free PMC article.
-
Fluorescence-Guided Surgery Using 5-Aminolevulinic Acid/Protoporphyrin IX in Brain Metastases.Neurosurg Pract. 2024 Nov 19;5(4):e00121. doi: 10.1227/neuprac.0000000000000121. eCollection 2024 Dec. Neurosurg Pract. 2024. PMID: 39959547 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical